Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/long-term-outcome-of-implantable-cardioverter-defibrillator-lead-MsISuc7kAy
References (3)
-
Erwin Ströker, C. Asmundis, P. Vanduynhoven, Katrien Vadder, P. Vusser, W. Mullens, G. Chierchia, P. Brugada, J. Czapla, M. Meir, F. Wellens, H. Herendael, M. Rivero‐Ayerza (2016)
Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator Lead.The American journal of cardiology, 117 5
-
Al-Khatib (2018)
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.Circulation, 138
-
J. Larsen, J. Nielsen, J. Johansen, J. Haarbo, H. Petersen, A. Thøgersen, S. Hjortshøj (2014)
Prospective nationwide fluoroscopic and electrical longitudinal follow-up of recalled Riata defibrillator leads in Denmark.Heart rhythm, 11 12
- Publisher
- American Medical Association
- Copyright
- Copyright 2019 American Medical Association. All Rights Reserved.
- ISSN
- 2168-6106
- eISSN
- 2168-6114
- DOI
- 10.1001/jamainternmed.2019.4717
- Publisher site
- See Article on Publisher Site
Abstract
This study compares outcomes of a recalled implantable cardioverter/defibrillator lead with a control lead in individuals in Iceland.
Journal
JAMA Internal Medicine – American Medical Association
Published: Feb 20, 2020